XML 101 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Pay vs Performance Disclosure [Table]    
Pay vs Performance [Table Text Block]
Year
Summary Compensation
Table Total for PEO
($)
Compensation
Actually Paid to
PEO1
($)
Average
Summary
Compensation
Table Total for
Non-PEO NEOs
($)
Average
Compensation
Actually Paid to
Non-PEO NEOs1
($)
Value of Initial Fixed $100
Investment Based on2:
Net Income3
($)
Company Selected Performance Measure - Organic Revenue
Growth4
Company Total Shareholder ReturnPeer Group Total Shareholder Return
202210,497,102 7,343,420 4,663,530 2,921,756 N/AN/A1,916,000,0007.3 %
  
Company Selected Measure Name Organic revenue growth  
PEO Total Compensation Amount $ 10,497,102  
PEO Actually Paid Compensation Amount 7,343,420  
Non-PEO NEO Average Total Compensation Amount 4,663,530  
Non-PEO NEO Average Compensation Actually Paid Amount $ 2,921,756  
Equity Valuation Assumption Difference, Footnote [Text Block] Compensation actually paid to our PEO and the average compensation actually paid to our non-PEO NEOs reflects adjustments from total compensation reported in the Summary Compensation Table. The assumptions used to calculate the values for RSUs and PSUs included in the calculation of compensation actually paid did not differ materially from those used to calculate grant date fair value for such awards. The assumptions used to calculate the value for stock options did not differ materially from those used to calculate grant date fair value for such awards. A Monte Carlo simulation model was used to calculate the fair value for PSUs. A Black-Scholes value was used for Options as of the applicable year-end or vesting date(s), determined using the same methodology used to determine grant date fair value, except that (a) the closing stock price on the applicable revaluation date was used as the current market price and (b) a reduced expected life was used, given applicable time lapse since grant date.  
Tabular List [Table Text Block]
Three Most Important Measures for Linking NEO Pay to Company Performance
•Organic revenue growth
•Operating profit
•Free cash flow
  
Net Income (Loss) $ 1,916,000,000  
Company Selected Measure Amount 0.073  
Additional 402(v) Disclosure [Text Block] GE HealthCare became an independent, public company effective January 3, 2023, but was required to report pursuant to Section 13(a) or 15(d) of the Exchange Act effective as of December 8, 2022.As reported in the 2022 Form 10-K.  
Measure [Axis]: 1    
Pay vs Performance Disclosure [Table]    
Measure Name Organic revenue growth  
Non-GAAP Measure Description [Text Block] Organic revenue for 2022 and 2021 was $18,873 million and $17,585 million, respectively, as reported in the 2022 Form 10-K.  
Measure [Axis]: 2    
Pay vs Performance Disclosure [Table]    
Other Performance Measure Amount 18,873,000,000 17,585,000,000
Measure Name Operating profit  
Measure [Axis]: 3    
Pay vs Performance Disclosure [Table]    
Measure Name Free cash flow